Robert E. WittesMedicine BranchSeminars in Surgical OncologyWittes RE. Small-cell lung cancer: an overview of issues in therapy. Sem Surg Oncol 1993;9:127-34Wittes RE. Small-cell lung cancer: an overview of issues in therapy. Semin Surg Oncol. 1993 Mar-Apr; 9 (2):127–134....
Small cell lung canceris an aggressive form of cancer. Previously, surgery was rarely considered because most patients present at the advanced stages of the disease. New research and the advances in medical imaging has challenged this notion proving that, as part of a multimodal treatment pathway,...
small cell lung cancer; treatment Abstract: Lung cancer was relatively uncommon at the turn of the 20th century, and has increased in prevalence at alarming rates, particularly because of the augmented trend in smoking, so that it is now the most common cause of cancer death in the world. ...
Ginsberg RJ. Surgery and small cell lung cancer—an overview. Lung Cancer 1989;5:232–236.Ginsberg RJ (1989) Surgery and small cell lung cancer: an overview. Lung Cancer 5:232–236Ginsberg RJ.Surgery and small cell lung cancer-an overview. Lung Cancer . 1989...
DelveInsights Small cell lung cancer (SCLC) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, ...
EORTC(European Organization for Research and Treatment of Cancer)的一项研究,将对化疗有反应的患者随机化分为2组,接受PCI或不接受PCI,发现PCI治疗组1年生存率为27.1%,未接受PCI者为13.3%。[49]在该研究中,PCI不仅减少脑转移的发生率也提高无病生存率和总体生存率。然而,欧洲肿瘤医学学会(ESMO)2010年的实践...
The discovery of the association between EGFR mutations and the efficacy of EGFR tyrosine-kinase inhibitors (TKIs) has revolutionized the treatment paradigm for patients with non-small-cell lung cancer (NSCLC). Currently, third-generation EGFR TKIs, which are often characterized by potent central nerv...
5 Potential Therapeutic Targets for Small Cell Lung Cancer ByHayden E. Klein January 28th 2025 Emerging Therapies Shine Hope on Small Cell Lung Cancer Treatment ByHayden E. Klein January 23rd 2025 Trilaciclib May Help Protect Against Chemotherapy Damage in Small Cell Lung Cancer ...
Clinical stage T1-2, N0 Limited stage in excess of T1-2, N0 NCCN Guidelines Version 2.2013 Small Cell Lung Cancer TESTING RESULTS Pathologic mediastinal staging h,i,j negative INITIAL TREATMENTk Lobectomy h,l (preferred) and mediastinal lymph node dissection or sampling N0 N+ Pathologic ...
Navigating treatment combinations in small-cell lung cancer The ETER701 trial demonstrates that a four-drug regimen, involving the addition of anti-angiogenesis therapy to immuno-chemotherapy, improves survival outcomes for extensive-stage small-cell lung cancer — but is more indeed better when it co...